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Abstract
Background:  Single Nucleotide Polymorphisms, among other type of sequence variants,
constitute key elements in genetic epidemiology and pharmacogenomics. While sequence data
about genetic variation is found at databases such as dbSNP, clues about the functional and
phenotypic consequences of the variations are generally found in biomedical literature. The
identification of the relevant documents and the extraction of the information from them are
hampered by the large size of literature databases and the lack of widely accepted standard notation
for biomedical entities. Thus, automatic systems for the identification of citations of allelic variants
of genes in biomedical texts are required.
Results: Our group has previously reported the development of OSIRIS, a system aimed at the
retrieval of literature about allelic variants of genes http://ibi.imim.es/osirisform.html. Here we
describe the development of a new version of OSIRIS (OSIRISv1.2, http://ibi.imim.es/
OSIRISv1.2.html) which incorporates a new entity recognition module and is built on top of a local
mirror of the MEDLINE collection and HgenetInfoDB: a database that collects data on human gene
sequence variations. The new entity recognition module is based on a pattern-based search
algorithm for the identification of variation terms in the texts and their mapping to dbSNP
identifiers. The performance of OSIRISv1.2 was evaluated on a manually annotated corpus,
resulting in 99% precision, 82% recall, and an F-score of 0.89. As an example, the application of the
system for collecting literature citations for the allelic variants of genes related to the diseases
intracranial aneurysm and breast cancer is presented.
Conclusion: OSIRISv1.2 can be used to link literature references to dbSNP database entries with
high accuracy, and therefore is suitable for collecting current knowledge on gene sequence
variations and supporting the functional annotation of variation databases. The application of
OSIRISv1.2 in combination with controlled vocabularies like MeSH provides a way to identify
associations of biomedical interest, such as those that relate SNPs with diseases.
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Background
In the last years the focus of biological research has shifted
from individual genes and proteins towards the study of
entire biological systems. The advent of high-throughput
experimentation has led to the generation of large data
sets, which is reflected in the constant growth of dedicated
repositories such as sequence databases and literature col-
lections. For instance, MEDLINE indexes more than 17
million articles in the biomedical sciences (by April
2007), and it's increasing at a rate of more than 10% each
year [1]. In this scenario, literature mining tools are
becoming essential for biomedical researchers, as they can
be used to extract, manage, integrate and exploit the bio-
logical knowledge recorded in the literature. Text mining
approaches are being applied to predict the function of
novel genes, for the functional annotation of molecules,
discovering protein-protein interactions, interpreting
microarray experiments, association of genes and pheno-
types, to only mention some applications (for review see
[1,2]).
The basis of any text mining system is the proper identifi-
cation of the entities mentioned in the text, also known as
Named Entity Recognition (NER). In biology, the entities
of interest are genes, proteins, chemical compounds, dis-
eases, tissues, and cellular components, among others.
Since naming of biological entities is inconsistent and
imprecise, tools that automatically extract the terms that
refer to the entities and link them to biological databases
are required [3]. NER has been an intense subject of
research in the last years, specially for the identification of
terms pertaining to genes and proteins [2]. The mapping
of a term to a database identifier (also referred to as nor-
malization) is important from a biomedical perspective,
because it provides the correct biological context to that
term. For instance, mapping a variation entity with a
dbSNP [4] identifier allows its unambiguous identifica-
tion, and in consequence all the information available for
this variation can be gathered (organism, genome loca-
tion, validation status, populations in which the variant
has been sequenced, biological sequences where the vari-
ant has been mapped, etc.). However, not all NER systems
include a normalization step. The first NER tools devel-
oped relied on manually devised rules that reflected typi-
cal features of gene and protein names as well as
contextual information provided by nearby words such as
"gene" or "protein" or "receptor" [5,6]. As annotated liter-
ature collections (corpora) in which gene and protein
names are manually tagged were available, application of
machine learning algorithms became feasible [6-10].
Contrasting, dictionary based methods rely on compre-
hensive lists of terms that are matched against the docu-
ments allowing variations in how the terms are written
[7,11-17]. The crucial advantage of dictionary based
approaches is that they allow the normalization of the
entities so far identified.
Contrasting to the extensive research carried out in the
field of gene and protein identification, few initiatives
have been directed to the task of identification of Single
Nucleotide Polymorphisms (SNPs) and other types of
sequence variants from the literature. The first approach
on this direction was MuteXt, which focused on collecting
single point mutations for two protein families: nuclear
hormone receptors (NR) and G-protein coupled receptors
(GPCR) [18]. MuteXt searched on full text articles looking
for protein mutations using regular expressions, achieving
a recall of 49.3% and 64.5%, and a precision of 87.9%
and 85.8% (for GPCR and NR, respectively). A related
approach has been implemented in MEMA [19], in which
regular expressions were used to extract variation-gene
pairs from MEDLINE abstracts. A difference with MuteXt
is that MEMA takes into account variations of the substi-
tution type both at the nucleotide and the amino acid lev-
els. Nevertheless, the MEMA system achieved a higher
performance (75% recall and 98% precision) for the iden-
tification and extraction of allelic variants from text. The
variation tagger Vtag [20] was developed for the identifi-
cation of several types of sequence variations related to
cancer in the literature. It is based on a probability model
called Conditional Random Fields. The reported perform-
ance of this method is quite good as it reaches 79% recall,
85% precision, and 82% F-score. Although the above
mentioned approaches represent nice examples of sys-
tems for the identification of variations, some of them are
specifically focused on specific protein family classes [18]
or diseases [20], and more importantly, none of these
methods tackle the problem of the normalization of the
variation entities so far identified. These features, how-
ever, are incorporated in the OSIRIS information retrieval
system (OSIRISv1.1 [21]). OSIRISv1.1 integrates different
sources of information and incorporates ad-hoc tools for
terminology generation with the aim of literature retrieval
about the allelic variants of a gene using the PubMed
search engine [22]. Although the use of OSIRISv1.1 helps
the researchers in the tedious task of searching literature
for sequence variants of genes, there was room for
improvement. For instance, the first implementation of
OSIRIS uses the PubMed search engine, and does not
include a NER system for the identification and tagging of
the terms within the text. The present article describes the
development of a new version of OSIRIS (herein referred
to as OSIRISv1.2). A key aspect was to develop a NER sys-
tem for identification and normalization of sequence var-
iants of human genes. The new implementation of OSIRIS
incorporates its own NER module and is built on top of a
local mirror of MEDLINE collection and HgenetInfoDB.
HgenetInfoDB is a database that integrates data on
human entries from the NCBI Gene database [23] andBMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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dbSNP [24]. The NER module is based on a corpus of arti-
cles automatically annotated with NCBI Gene identifiers
and the new OSIRISv1.2 search algorithm. The new
OSIRISv1.2 search algorithm uses a pattern matching
based search strategy and a sequence variant nomencla-
ture dictionary for the identification of terms denoting
SNPs and other sequence variants and their mapping to
dbSNP identifiers. The use of OSIRISv1.2 on MEDLINE
abstracts generates a corpus of annotated literature linked
to sequence database identifiers (NCBI Gene and dbSNP).
The performance of OSIRISv1.2 was evaluated on a man-
ually annotated corpus, resulting in 99% precision, 82%
recall, and an F-score of 0.89. As an example, the applica-
tion of the system for collecting literature for the allelic
variants of genes related with two complex diseases
(intracranial aneurysm and breast cancer) is presented.
Results and Discussion
Development of a NER system for gene sequence variants
Our group has previously reported the development of
OSIRISv1.1 [21], a tool for the retrieval of literature asso-
ciated to the allelic variants of a gene based in the PubMed
search engine. With the aim to improve the recognition of
variations from text in terms of recall and precision we
developed OSIRISv1.2, based on its own NER algorithm
and local data sources (MEDLINE abstracts and Hgenet-
InfoDB). In addition, we paid special attention to the nor-
malization of the genetic variants, as it provides
biologically relevant contextual information.
The work flow of OSIRISv1.2 is detailed in the Methods
section and illustrated in Figure 1. Briefly, OSIRISv1.2
scans MEDLINE abstracts, identifies texts passages corre-
sponding to variation terms, and disambiguates the terms
to dbSNP identifiers. The results are stored in the Text-
MiningDB database, and a web interface for the query and
visualization of the results was developed [25]. Results for
two diseases used as test cases are currently available in
the database. A description of these results can be found
in the section "Application of OSIRISv1.2 for finding
sequence variants information on a set of aneurysm-
related genes". In the following section, a brief description
of the user interface is presented.
1. User interface
The user interface offers two possibilities for browsing the
results of OSIRISv1.2 on the test cases. The results can be
queried by a gene-centred search approach on the basis of
the related disease (breast cancer or intracranial aneu-
rysm), or by using MeSH disease terms (Figure 2).
1.1. Gene-centred search approach
By using this modality of search, a list of the genes for
which results were found are presented. Two possibilities
for browsing the results on these genes are available: "See
Variants" and "See References" (Figure 3). By clicking the
link "See Variants", a page comprising two pieces of infor-
mation is displayed on the browser: dbSNP-related infor-
mation for the gene and literature-related information
(Figure 4). The first includes the sequence variants
described for the gene. This information is provided by
the database HgenetInfoDB and is organized in tabular
format with several hyperlinks. The sequence variants are
classified according to their mapping to the gene sequence
in coding or non-coding regions of the gene. The table
includes the following information for each dbSNP entry:
the unique identifier from dbSNP (rs number), the type of
variant (e.g. "single base" for a SNP or "dips" for an inser-
tion/deletion polymorphism), the position of the variant
relative to the gene sequence, the alleles, and specifies the
mapping or location of the variant (in coding sequences:
synonymous or non-synonymous variants; in non-coding
sequences: located in introns, splice-sites, untranslated
regions, etc.). In addition, the identifiers of the mRNA and
protein sequences are provided in the case of SNPs that
map to coding sequences. In the case of variations located
in coding regions, the position and amino acidic residues
of the variation in the protein sequence are shown. The
data are provided with hyperlinks to the corresponding
data sources (dbSNP and NCBI Gene).
Regarding the literature information, the last column in
the table indicates if any reference was found for each
dbSNP entry, and provides a link to another page where
this information is detailed (Figure 5). In this page, the
data is organized by dbSNP entry, displaying the text pas-
sages where a term representing the dbSNP entry was
identified by OSIRISv1.2. These terms are highlighted to
aid visualization and contain hyperlinks to dbSNP. Three
colouring codes are used: the terms corresponding to the
current dbSNP entry appear in red, in light blue the terms
corresponding to other sequence variants found in the
text, and in yellow the terms that are mapped to more
than one dbSNP identifier. In addition, a table showing
the terms from the Disease category of the MeSH hierar-
chy extracted from the set of abstracts annotated to the
variation is provided (Figure 5, inset).
By using this approach, the reader is directly pointed to
the text passages where SNPs, for instance, are mentioned.
In addition, the PMID of the corresponding article is pro-
vided with its hyperlink to the abstract, giving the reader
the opportunity to review the complete abstract.
Another view of the results is displayed by clicking "See
References", where text passages from all the abstracts
found for the sequence variants of the gene are shown.
Again, the terms corresponding to the variants are high-
lighted and contain hyperlinks to dbSNP. Three colouring
codes are used: the variants mapped to the current geneBMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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appear in red, and in light blue the variants belonging to
other genes, in yellow the variants that are mapped to
more than one dbSNP identifier.
1.2. MeSH term search approach
The results can also be queried using the MeSH Disease
terms (Figure 2). Variations associated to the main Dis-
ease categories from the MeSH hierarchy can be retrieved.
For instance, genetic variants associated with Muscu-
loskeletal Diseases or Cardiovascular Diseases, both
examples of broad categories of diseases in the MeSH hier-
archy, can be retrieved using this search modality. The
results are organized in a table showing the variants
described in association with the disease in the literature
(Figure 6). Alternatively, the MeSH disease terms associ-
ated to an specific dbSNP entry through the literature can
be obtained as well. This functionality provides a pheno-
typic description in the disease area for the allelic varia-
tions of a gene. These results are also shown using the
gene-centred search modality.
It is worthwhile to mention that not all the terms that refer
to variations in the text passages shown in OSIRISv1.2
output are highlighted. This is due to the following rea-
sons: 1 – not all the variants mentioned in the text can be
mapped to a dbSNP identifier; 2 – the variant mentioned
OSIRISv1.2 system work flow Figure 1
OSIRISv1.2 system work flow. The system is based on a local mirror of MEDLINE database and HgenetInfoDB, which inte-
grates information for human Gene and dbSNP databases from the NCBI. The starting point of the system is a gene, for which 
a set of articles is annotated using the NER tool ProMiner and stored in the TextMiningDB (1). The gene-specific corpus is 
accessed by OSIRISv1.2 (2) to obtain the MEDLINE citations annotated to a NCBI Gene entry. The corresponding MEDLINE 
abstracts are retrieved from a local repository (3). In addition, sequence data for each gene and its sequence variants are 
retrieved from HgenetInfoDB, and this information is used to generate the SNP terminology (4). The next step of OSIRISv1.2 
is the search for occurrences of the sequence variant terms in each gene-specific corpus by processing the MEDLINE abstracts. 
This information (SNP-specific corpus) is returned to the TextMiningDB database (5). The results of OSIRISv1.2, stored in the 
TextMiningDB, can be accessed through our web interface at [25]. GenDB: data retrieval system used for conversion of the 
XML files to the files in MEDLINE format, indexing of the MEDLINE files and for their retrieval (internal development of FhG-
SCAI by Theo-Heinz Mevissen). ProMiner has been described elsewhere [15]. For simplicity we use in this figure the term SNP 
to refer to all variations present in the database (SNPs and other types of sequence variants).
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in the text is mapped to a gene for which a OSIRISv1.2
search has not been performed; 3 – the level of recall of
the search algorithm (see below in Evaluation).
In summary, the use of OSIRISv1.2 provides a way to
access to the literature reported for the allelic variants of a
gene of interest in a few mouse clicks. In addition, it iden-
tifies and highlights the terms corresponding to the allelic
variants aiding in the visualization of the search results,
and therefore saving time for the user.
Evaluation
An evaluation was carried out to assess the performance of
OSIRISv1.2. This kind of evaluation requires a set of refer-
ence documents that are judged as relevant or irrelevant
for a certain query, i.e. a corpus or gold standard
(described in Methods: Evaluation of OSIRISv1.2 per-
formance). A manually annotated corpus was developed
for the purpose of the evaluation of the sequence variant
extraction and normalization tasks. This is a valuable
accomplishment since there is high demand of such
standards for evaluation purposes [26]. The corpus is
available upon request.
The evaluation consisted in assessing of both the identifi-
cation of the terms that refer to variations and the normal-
ization of these terms. The result of the evaluation
indicated that the algorithm is geared towards high preci-
User interface: search modes Figure 2
User interface: search modes. The user interface offers two possibilities for querying the results of OSIRISv1.2. The results 
can be queried by a gene-centred search approach, selecting the disease of interest (breast cancer or intracranial aneurysm), or 
by using MeSH disease terms.BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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sion (99%) at a recall of 89%, resulting in an F-score of
0.94, for the recognition of variation terms and disam-
biguation to dbSNP identifiers.
A comparison of the performance of all the current meth-
odologies is shown in Table 1. Both versions of OSIRIS
were evaluated on the corpus developed in this study.
Regarding the other approaches, although the results of
the evaluations carried out in each case are not directly
comparable (different corpora and evaluation criteria
were used), it serves as a rough comparison with the pub-
lished methods.
The evaluation for OSIRISv1.2 shows satisfactory results
for both precision and recall. The low recall of OSIRISv1.1
could be explained by the inability of the query expansion
approach used by the system to recover all the variation
specific terms. The recall is increased in the new imple-
mentation by improvement of both the recognition of
gene and variation terms. Regarding the other approaches,
published results indicate that the MEMA system [19]
achieved a 75% recall and 98% precision for the recovery
of mutations from texts. MEMA uses regular expressions
for finding mutations-gene pairs, but it does not provide
mapping to dbSNP entries. In this system, the association
of a mutation with a gene is done by co-occurrence of
both terms in a sentence. Contrasting, OSIRISv1.2 uses
co-occurrence and a sequence based approach. The Vtag
approach [20], based on a probabilistic model to identify
mutation terms, achieves a high recall level, but without
providing mapping to sequence database entries. The
strategy used by OSIRISv1.2 provides a way to achieve rec-
ognition and mapping of variation terms to dbSNP iden-
tifiers with high precision and recall, which are very
important features for database annotation purposes and
mining information from text. In addition, the results of
the evaluation indicates that a simple search algorithm
performs well in the task of NER and normalization of
sequence variants. The recall could be further improved
by recognition of complex expressions representing
sequence variants, such as "G/A genotype associated with
tumour necrosis factor-alpha promoter positions -376
and -244". Future implementations including a broader
terminology will probably achieve higher recall levels.
Other factor having a negative impact on OSIRISv1.2
recall are the lack of agreement between the numbering of
variants position in articles and the one found in data-
bases for some variations.
As mentioned above, the approach used by OSIRISv1.2 to
correctly link a variation with a gene is based on co-occur-
rence of gene and variation terms in the text and sequence
mapping. Nevertheless, in some cases it is not possible to
assign a variation to a gene in an unambiguous manner.
This occurs when two genes and their sequence variants
are mentioned in the abstract, and, just by chance, the var-
iants share some of the features required for normaliza-
tion (the position and the alleles). In such cases, the term
will be annotated with two dbSNP identifiers that are
mapped to different genes, leading to an ambiguous
annotation. These cases are highlighted in yellow in the
results displayed on the web.
In order to study in what extent this situation leads to
ambiguous annotations, we conducted the following
evaluation. We assessed the number of terms referring to
a variation that were assigned to more than one dbSNP
identifier by OSIRISv1.2. This evaluation was conducted
on all the data present in the TextMiningDB (by August
2007). We found that 2.5% (21/841) of the variations
had been annotated with more than one identifier from
dbSNP. From this set, 0.24% (2/841) resulted from an
incorrect identification of a gene term by ProMiner, 1.5%
(13/841) were due to multiple annotations in dbSNP, and
0.7% (6/841) resulted from an incorrect assignment of
the variation to the term. Multiple annotations in dbSNP
occur when a variation has more than one dbSNP identi-
fier (see for example the dbSNP identifiers 1059455 and
41548918 at dbSNP site), and are merged in subsequent
updates of the database. This means that 1.5% of the cases
are not really ambiguous: the dbSNP identifiers assigned
point to the same variation in the gene sequence.
In summary, only 0.7% of annotations are ambiguous
due to the inability to distinguish between multiple
dbSNP identifiers for a single variation, and lead to an
incorrect linkage of variation and gene. The ambiguous
annotations are shown in Table 2.
Application of OSIRISv1.2 for finding sequence variant 
information on a set of aneurysm related genes
Two complex diseases were used as test cases for the sys-
tem: breast cancer and intracranial aneurysm and sub-
arachnoid haemorrhage. The results can be queried
through the web interface [25]. Only results for intracra-
nial aneurysm will be discussed as an example. A sum-
mary of the data present in the TextMiningDB database is
shown in Table 3.
Subarachnoid haemorrhage as a consequence of intracra-
nial aneurysm is one of the most devastating cerebrovas-
cular diseases due to its high morbidity and mortality.
Cerebral aneurysms are extensions of arterial vessels in the
brain. These extensions are balloon-type bulges that form
in apparently healthy people with a comparably high fre-
quency (about 2% of the general population have an
intracranial aneurysm) [27]. The interaction of genetic as
well as environmental risk factors are thought to play an
important role in the pathogenesis and prognosis of the
disease. In addition to smoking, hypertension, arterioscle-BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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rosis and alcohol intake, haemodynamic stress at arterial
bifurcations is believed to contribute to the development
of aneurysms [28]. Several studies have claimed that the
presence of certain allelic variants may increase the indi-
vidual's susceptibility to develop intracranial aneurysms,
and might be used as biomarkers for the risk of aneurysm
rupture [28,29]. In this context, the identification of the
sequence variants associated to the disease phenotype in
specific populations is of high value for early diagnosis
and treatment, and also for providing an understanding of
the pathogenesis of the disease. OSIRISv1.2 was utilized
for collecting sequence variants data for a set of genes
related to the disease, and for the identification of SNP
terms from MEDLINE abstracts, with the aim of collecting
the available information on the variants under study in
the disease.
Gene-centred search results Figure 3
Gene-centred search results. By using the gene-centred search approach, a list of the genes for which results were found 
for the selected disease are presented, sorted in alphabetical order. Two possibilities for browsing the results on these genes 
are available: "See Variants" and "See References". By clicking the link "See Variants", a page comprising two pieces of informa-
tion is displayed on the browser: dbSNP-related information for the gene and literature-related information (see Figure 4). By 
clicking "See References", text passages from all the abstracts found for the sequence variants of the gene are displayed, in a 
format similar to the one illustrated in Figure 5.BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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A set of aneurysm-related genes was automatically identi-
fied on the basis of their occurrence in abstracts pertaining
to the disease. The abstracts related to the disease were
retrieved using PubMed search engine with the queries
described in Methods and scanned with ProMiner [15].
This resulted in a set of 771 genes, to which 202699 vari-
ations are mapped according to dbSNP. Then, OSIRISv1.2
was used to search literature citations for the dbSNP
entries mapped to the 771 aneurysm-related genes. Since
the searches performed on the abstracts belonging to the
aneurysm-related corpora resulted in a small number of
OSIRISv1.2 annotations (data not shown), the searches
were then conducted in the entire MEDLINE collection.
Results were obtained for 271 genes and 868 variants,
which were found to be linked to 3149 citations (Table 2).
These results represent a collection of the citations that
refer to sequence variants on these genes, and are available
at [25].
To illustrate the kind of insights that can be obtained
using OSIRISv1.2, the gene for the endothelial nitric oxide
synthase or eNOS, (NOS3, NCBI Gene Id 4846) will be
Information for the sequence variants of the gene Figure 4
Information for the sequence variants of the gene. The link "See Variants", displays a page comprising two pieces of 
information on the browser: dbSNP-related information for the gene and literature-related information. The first includes the 
sequence variants described for the gene. The sequence variants are classified according to their mapping to the gene sequence 
in coding or non-coding regions of the gene. The table includes the following information for each dbSNP entry: the unique 
identifier from dbSNP (rs number), its validation status and allele frequency, the type of variant (e.g. "single base" for a SNP or 
"dips" for an insertion/deletion polymorphism), the position of the variant relative to the gene sequence, the alleles, and speci-
fies the mapping or location of the variant (in coding sequences: synonymous or non-synonymous variants; in non-coding 
sequences: located in introns, splice-sites, untranslated regions, etc.). In addition, the identifiers of the mRNA and protein 
sequences are provided in the case of SNPs that map to coding sequences. In the case of variations located in coding regions, 
the position and amino acidic residues of the variation in the protein sequence are shown. The data are provided with hyper-
links to the corresponding data sources (dbSNP and NCBI Gene). The last column of the table indicates if any reference was 
found for each dbSNP entry, and provides a link to another page where this information is detailed (see Figure 5).BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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used as an example. NOS3 is one of the candidates for the
pathogenesis of intracranial aneurysm, and its association
with the disease has been addressed by several studies [30-
33]. Moreover, it might be involved in the observed sex
differences in the outcome of subarachnoidal haemor-
rhage as a consequence of intracranial aneurysms [34].
Endothelial nitric oxide synthase is one of the three iso-
forms of the enzyme nitric oxide synthase. Nitric oxide
(NO) is important in the regulation of vasomotor tone
and blood flow by inhibiting smooth muscle contraction
and platelet aggregation. Mice lacking NOS3 gene are
hypertensive and the combined deletion of NOS3 and
apolipoprotein E confers an increased susceptibility to
arteriosclerosis. The production of NO is regulated at the
level of NOS3 gene expression and activity of the enzyme.
The promoter of the gene contains transcription factor
binding sites that mediate regulation by shear stress and
oestrogens [35].
Several citations were found to refer to variations in the
NOS3 gene by OSIRISv1.2. The analysis that follows is
based on the literature citations found by OSIRISv1.2 for
one of the most studied variants of the gene (dbSNP
rs1799983, 255 citations found). Regarding the associa-
Literature references for the sequence variants of a gene Figure 5
Literature references for the sequence variants of a gene. The data is organized by dbSNP entry, displaying the text 
passages where a term representing the dbSNP entry was identified by OSIRISv1.2. These terms are highlighted to aid visuali-
zation and contain hyperlinks to dbSNP. Three colouring codes are used: the terms corresponding to the current dbSNP entry 
appear in red, in light blue the terms corresponding to other sequence variants found in the text, and in yellow the terms that 
are mapped to more than one dbSNP identifier. In addition, a table showing the terms from the Disease category of the MeSH 
hierarchy extracted from the set of abstracts annotated to the variation is provided (inset).BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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tion with aneurysm, the rs1799983 variant has been
described as one of the genetic factors related to the risk of
aneurysm rupture in a population from USA (PMID
15796389). Although this finding could not be replicated
in a Japanese population (PMID: 17121133), the
rs1799983 variant was found to be a mild predisposing
factor for abdominal aortic aneurysm, a chronic degener-
ative condition associated with arteriosclerosis (PMID:
16171581). The putative association of this variant with
diseases other than aneurysms has been extensively inves-
tigated, as shown by the MeSH disease terms extracted
from the set of articles annotated to this variant: Hyper-
tension, Pre-eclampsia, Myocardial Infarction, Alzheimer
disease. Deregulation of vascular homeostasis is a com-
mon factor among the above mentioned diseases, appear-
MeSH terms search results Figure 6
MeSH terms search results. As shown in Figure 2, the results can also be queried using the MeSH Disease terms. Varia-
tions associated to the main Disease categories from the MeSH hierarchy can be retrieved. The results are organized in a table 
showing the variants described in association with the disease in the literature, and the weights assigned to each term. This 
functionality provide a phenotypic description in the disease area of the variations. These results are also shown using the 
gene-centred search modality.
Table 1: Comparison of the performance of NER methods for 
sequence variants.
Method Precision Recall F-score
OSIRISv1.1 0.97 0.3 0.46
OSIRISv1.2 0.99 0.82 0.89
Vtag 0.85 0.79 0.82
MuteXt* 0.87 0.57 0.67
MEMA 0.98 0.75 0.85
OSIRISv1.1 and OSIRISv1.2 were evaluated on the corpus described 
in this study. Performance of other methods correspond to published 
data for each development. Since the use of different benchmarks and 
the different evaluation criteria make the results not strictly 
comparable, the results can only be considered for a rough 
comparison of the state of the art. *Average of evaluation on two 
protein families reportedBMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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ing as a symptom or as a risk factor. The association of the
rs1799983 variant with these phenotypes might be reflect-
ing a common mechanism in the disease pathogenesis.
The rs1799983 variant, although leads to a conservative
change in the protein sequence (Glu to Asp at position
298), would have functional consequences, as suggested
by studies showing that the Asp residue is subjected to
selective proteolytic cleavage in endothelial cells and vas-
cular tissues (PMID: 10717002, PMID: 11823442) that
impairs NO production (PMID: 12065317). However,
recent findings have challenged these observations
(PMID: 11331296, PMID: 15608562). Thus, it is likely
that any relationship between the variant and the disease
phenotype is due to this being an indirect marker of the
genetic association rather than a direct functional effect.
Alternatively, a different functional effect of the variant
(e.g. in alternative splicing or in protein folding) might
explain the observed clinical features under pathological
conditions. Further work is required to clarify the kind of
relationship (functional or indirect) of the rs1799983 var-
iant with the disease phenotypes.
Conclusion
In this report we present OSIRISv1.2, a system for collect-
ing the current knowledge about gene sequence variants
from the literature. The evaluation of OSIRISv1.2 on a
manually annotated corpus showed that it achieves high
precision (99%) and recall (82%) in named entity recog-
nition and disambiguation of terms. The NER system that
is the basis of OSIRISv1.2 was combined with a NER sys-
tem for genes and proteins (ProMiner) that in turn will
form the basis of a disease centric information system by
integrating NER with disease specific biomedical literature
search. This integrated system will allow the extraction of
information related to genotype-phenotype relationships
in human diseases. The architecture of the system allows
incorporation of additional modules, such as NER mod-
ules for drugs and diseases, and modules for mining rela-
tionships between the entities so far identified. In
addition, automatic systems for updating the text mining
results allow to keep up to date the extracted information.
To demonstrate the usefulness of the approach,
OSIRISv1.2 was applied for the development of a data-
base of literature references associated with allelic variants
of genes related with two complex diseases: intracranial
aneurysm and subarachnoid haemorrhage, and breast
cancer. As illustrated with the example on one of the SNPs
of the NOS3 gene, several interesting pieces of informa-
tion regarding related phenotypes and functional effects
of a variation can be easily obtained using OSIRISv1.2.
The approach also illustrates the strategy for linking
genetic variants of genes present in sequence databases
(dbSNP) with disease terms of a controlled vocabulary
(MeSH vocabulary) through the literature. Moreover, this
approach could be used for developing similar databases
focused in other diseases. Although the system has been
implemented for human genes, the general approach is
Table 2: Detail of ambiguous annotations by OSIRISv1.2
PMID Term dbSNP identifier
10087990 10383894 15941956
14557859 15894659 11096344
15668490
142Ser 3817672
1799830
14605322 261C > T 1043428
11547635
10030842 774C/T 1549758
34112109
15372320 79T > C 40401
4986964
8655358 Asp86 17880292
17885129
1059350
34095932
17100549 Pro25 1800471
2227647
The table show the cases where an ambiguous assignment of a dbSNP 
identifier to a variation term was obtained. The first column depicts 
the PMID of the abstracts where the term (second column) was 
found. The third column shows the dbSNP identifiers assigned to the 
term by OSIRISv1.2. Highlighted in bold are the correct assignment of 
dbSNP identifier to that term. In some instances the information from 
the text does not allow to discern between two SNPs occurring at 
the same position in the protein sequence but differing only in one of 
the alternative residues. For example, for the "Asp86" term, both 
SNPs highlighted in bold represent changes at position 86 of the 
protein in which an Asp residue is involved. One is a synonymous 
change while the other is non-synonymous. However, the information 
extracted from the text is not sufficient to distinguish among these 
two possibilities (only one allele is described: the Asp residue), and 
therefore both identifiers are assigned to the term.
Table 3: Summary of OSIRISv1.2 results available on the 
TextMiningDB
Intracranial aneurysm Breast cancer All
PMIDS 3149 7769 7870
Gene Id 271 868 895
dbSNP Id 868 2442 2507
Results for the diseases intracranial aneurysm and breast cancer were 
compiled. The disease-specific corpora were built using PubMed and 
the queries described in the Methods section. The genes described in 
each corpora were extracted using ProMiner, and a list of genes 
specific for each disease was obtained. Then, OSIRISv1.2 searches 
were performed for each list of genes on the whole MEDLINE 
collection. Results presented in the table correspond to the 
MEDLINE collection at August 2007.BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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easily applicable to other organisms with variation data
available (e.g. mouse).
OSIRISv1.2 is focused in identifying the terms from text
that represent variations from reference sequence reposi-
tories such as dbSNP. The combined use of OSIRISv1.2
(NER and normalization) and any other NER that search
for variation entities in general without normalization
(any of the methods mentioned in the Background sec-
tion) would provide with two sets of SNP data that could
be of interest to dbSNP curators. In this regard, we antici-
pate that a suitable application of OSIRISv1.2 would be
for supporting the functional annotation of dbSNP
entries. This is a relevant issue since the unravelling of the
biological consequences of sequence variants remains a
challenging task. In addition, elucidation of the func-
tional impact of predisposing SNP alleles identified by
genome wide association studies has important implica-
tions in terms of understanding the underlying biology of
complex diseases and identifying putative therapeutic tar-
gets.
Methods
OSIRISv1.2 system work flow
A schematic view of the work flow of the system is shown
in Figure 1. The starting point of OSIRISv1.2 is a gene, for
which a set of annotated abstracts is obtained. The anno-
tation of MEDLINE abstracts with NCBI Gene identifiers
is performed with the NER tool ProMiner [15], but any
other NER system that performs normalization to NCBI
Gene identifiers could be used as well. The ProMiner sys-
tem was tested in the BioCreAtIvE I and II assessments for
the detection of gene and protein names on different
organisms [36,37]. The system achieved for all tested
organisms excellent results and for human an F-score of
80% with a precision of 83% and a recall of 77%.
ProMiner runs performed on the entire MEDLINE collec-
tion are used for OSIRISv1.2. This involves a scanning of
the abstracts in search for the human entries of NCBI
Gene [23] and SwissProt [38] databases. The results of the
ProMiner runs are stored in a database (TextMiningDB),
and are accessed by OSIRISv1.2 to obtain the corpus of
MEDLINE citations annotated to a NCBI Gene entry. The
corresponding MEDLINE abstracts are retrieved from a
local repository and stored for later processing. In addi-
tion, sequence data for each gene and its sequence vari-
ants are retrieved from HgenetInfoDB (described below).
Using the information obtained from HgenetInfoDB,
OSIRISv1.2 generates a dictionary of terms for each vari-
ant representing the more frequently used terminology for
the variant. The next step of OSIRISv1.2 is the search for
occurrences of the sequence variant terms in each gene-
specific corpus by processing the MEDLINE abstracts.
Once a variation term is found, the dbSNP identifier is
assigned to it. This information is returned and back prop-
agated to the TextMiningDB database (Figure 1).
The approach used by OSIRISv1.2 to link a variation with
a gene is based on co-occurrence of variation and gene
terms in the abstract and sequence mapping. Only the var-
iations mapped to the gene are searched on the text of the
gene-specific abstracts (Figure 1). The annotation of vari-
ations to a given gene is obtained from dbSNP (for a
description see [39]). This procedure allows the identifica-
tion of the term that refers to a variant and the assignment
of a dbSNP identifier to that term (normalization). Nor-
malization of a term provides biological contextual infor-
mation: for instance, the gene to which this variation is
mapped to can be obtained, as well as other gene products
(mRNA and protein sequences), and other potentially
useful information (population frequency data, state of
validation, etc.). In addition, by assignment of a dbSNP
identifier to a variation, its linkage to the gene to which
the variation is mapped to is established.
OSIRISV1.2 search algorithm
A search algorithm for identification of sequence variants
terms in biomedical text and mapping to dbSNP identifi-
ers was developed. The search is performed for all the var-
iants mapped to the gene of interest on a gene-specific set
of abstracts (see Figure 1). The data related to the
sequence variants of a gene was obtained from Hgenet-
InfoDB, which is used to build the terminology. The ter-
minology for each variant was generated by a term
extension approach according to a set of patterns manu-
ally developed after inspecting the literature for collecting
usual natural language expressions used to represent
sequence variants. Currently, the collection of amino
acidic terminology is built by 286 terms, while the nucle-
otidic terminology is composed of 114 terms for each var-
iant (some examples are depicted in Table 4). The search
is performed using pattern matching of the terms from the
terminology to text passages. The rationale behind the
search algorithm is that for the identification and unique
mapping of a text passage representing a sequence variant
to a dbSNP identifier, both the position and alleles of the
variant are required. Thus, the search algorithm involves
two steps: first, the number representing the variant posi-
tion in the gene, mRNA or protein is searched (for
instance in the case of Ala12Val, the number 12 is
searched in the text). This step selects sentences that are
candidates for having a mention of the variation under
search. Then, only the candidate sentences are examined
for the complete variation terms. A window of a pre-
defined length is extracted from the text around the
matched number on the candidate sentence, and the rele-
vant term (e.g. Ala12Val and all its variants: Val12Ala,
A12V, ...) is searched by exact-pattern matching in this text
fragment. Once a match is found, the position of the pat-BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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tern in the abstract is computed and stored in the data-
base. This information is then used for visualization
purposes, and will be useful for information extraction
tasks. As the terms are attached to a dbSNP identifier, once
a term is identified in the text, its disambiguation to a
database identifier is automatically achieved. The algo-
rithm is implemented in Python 2.4.1.
Databases
A database integrating information on human genes and
its sequence variants was developed (HgenetInfoDB).
Data for human genes were obtained from NCBI Gene
database (release June 2006), and data for sequence vari-
ants, including SNPs, indels, etc., were obtained from
NCBI dbSNP (build 127). NCBI dbSNP was chosen
because is one of the main repositories of variation data
and is highly interlinked with other sequence databases
within the NCBI. The NCBI Gene database is provided as
XML files. For collecting Gene data, the XML file for each
human gene was parsed for extraction of relevant infor-
mation using Python scripts. The data were stored in tab-
separated files, suitable for direct importing into database
tables. Contrasting to NCBI Gene, dbSNP provides its
data as tables that can be directly imported into the data-
base. Only a selection of all the available tables for Homo
sapiens (build 126) were downloaded [24] and loaded
onto the database (tables SNPContigLocusId, ContigInfo,
UniVariation, SNP, SnpFunctionCode and SnpClass-
Code). Only variants mapped to the reference genome
assembly were included in the database. Then, processing
and transformation of the data was performed within the
database using SQL statements. Among other pieces of
information, HgenetInfoDB contains the position of the
variant relative to the gene sequence, to the spliced mRNA
sequence and to the protein sequence, and information
regarding the alternative alleles for each variant. This data
is used to generate the terminology. The database was
implemented in MySQL version 5.0.15. The current ver-
sion of the database contains 28998 entries from the Gene
database and 4527470 dbSNP entries mapped to a Gene
Id.
The results of the OSIRISv1.2 and ProMiner searches were
also stored in a relational database (TextMiningDB). This
database serves the following purposes: storage of the
ProMiner results, which are required for the OSIRISv1.2
searches, storage of the OSIRISv1.2 search results, and for
query of results for visualization.
Abstracts in MEDLINE format were used throughout the
study. The results here presented correspond to the
MEDLINE collection updated to August 16th 2007. The
results available on the web server are regularly updated.
The abstracts are accessed from a local mirror of
MEDLINE repository. The GenDB generic data retrieval
system is used for conversion of the XML files to the files
in MEDLINE format, indexing of the MEDLINE files and
for their retrieval (internal development of FhG-SCAI by
Theo-Heinz Mevissen).
MeSH terms
MeSH [40] terms belonging to the Disease category were
chosen to describe the set of articles found to be associ-
ated to a dbSNP entry by OSIRISv1.2. The Disease cate-
gory is formed by 23 sub-categories covering human
diseases, with the exception of the C22 branch ('Animal
Diseases') which was excluded from the analysis. The
branch F03 representing Mental Disorders was added in
order to add coverage for psychiatric diseases not included
in the above mentioned 23 categories. MeSH terms are
assigned to each MEDLINE abstract by experts in the field
who read the full text article and choose the most repre-
sentative terms from the controlled vocabulary for
describing the contents of the article. Therefore, MeSH
terms represent good descriptors of the topics covered by
the article.
Terms from the Disease category of the MeSH [40] hierar-
chy were extracted from the set of abstracts associated to
each dbSNP entry. A weight was assigned to each term, as
an indicator of the relevance of the term in describing the
set of articles associated to each variation. The weights
were computed for the set of documents annotated to a
variation by OSIRISv1.2, according to the TF × IDF scoring
system, frequently used in text-mining applications [41].
As each MeSH term occurs just once in a document, and
we wanted to compute the weight of terms for a set of doc-
uments (the set of documents assigned to a variation), the
TF was computed as a measure of document frequency of
the term in a set of documents. The Term Frequency or TF
reflects the importance of the MeSH term in the set of arti-
cles associated to a variation (i.e. the fraction of docu-
ments with a particular MeSH term), while the Inverse
Document Frequency or IDF accounts for the inverse fre-
quency of documents containing the MeSH term in the
whole MEDLINE collection. Thus, the Weight or W,
defined as TF × IDF, is a composite weight measure for
Table 4: Terminology for sequence variants.
Amino acid terminology Nucleotide terminology
Q610R A-161G
R610Q G-161A
Gln610Arg G(-161)A
Arg610Gln -161 A-G
Gln (610) Arg -161 G-A
Arg (610) Gln -161 (A-G)
610 Gln > Arg A(-161)G
610 Arg > Gln -161 (G-A)
Some examples of the terms generated by the system are shown.BMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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each term in a set of documents. By using this scoring sys-
tem, a term is assigned a weight that is: highest when the
term occurs in most of the documents belonging to the
document set; lower when the term occurs in only a small
proportion of the document set, or occurs in many docu-
ments from the MEDLINE collection; and lowest when
the term occurs in almost all the documents from the
MEDLINE collection.
This representation, in addition to be useful for describing
the topics covered by the set of documents related to a
dbSNP entry, provides an easy way to retrieve the varia-
tions that are associated to a disease, according to the
MeSH controlled vocabulary. A search functionality using
the MeSH disease terms was also included in the web
interface (see description in the Results and Discussion
section: User interface).
Evaluation of OSIRISv1.2 performance
Our goal was to assess the processes of entity recognition
and subsequent normalization of genetic variations. The
entity recognition of gene and protein terms by ProMiner
has been evaluated elsewhere [36,37]. The performance of
OSIRISv1.2 was estimated by computing its precision
(number of correctly identified entities divided by the
total number of entities identified), recall (number of cor-
rectly identified entities divided by the total number of
entities in the text) and F-score (weighted average of pre-
cision and recall, (2·precision·recall)/(preci-
sion+recall)). The values of precision and recall were
computed for the combined process of entity recognition
and normalization: that means that a match was consid-
ered a true positive when a genetic variation term was
identified and disambiguated to the correct dbSNP identi-
fier; otherwise, it was computed as false positive. Thus, the
assignment of a correct dbSNP identifier to an entity
found in the abstract text implies the establishment of a
correct linkage between the gene and the variation.
Some of the corpora developed for evaluation of text min-
ing applications in the biomedical domain [26] were con-
sidered with respect to their suitability for the evaluation
of OSIRISv1.2. They were GENIA corpus [42], PennBioIE
oncology and PennBioIE cyp [43]. However, none of
them were found suitable for the task because of the low
occurrence of sequence variant terms in the documents
included in these corpora. Another source of sequence
variant annotation of the literature is provided by the link-
age between dbSNP and PubMed supplied by the NCBI.
These links were studied to assess if they could be used for
compiling a set of articles annotated with dbSNP entries.
It was observed that the aforementioned links were only
established between articles that describe genotyping
projects involving large fragments of chromosomes and
the dbSNP entries that are mapped to these chromosomal
fragments. These links are generated by connecting sub-
missions to dbSNP to PubMed records of publications
cited at the time of submission [44]. For instance, for
76,438 dbSNP entries only 32 different articles were
annotated. Moreover, only a small proportion of the
abstracts included in their text a direct mention of a spe-
cific dbSNP entry. In the case of the aforementioned 32
articles, only 10 abstracts mentioned specific SNPs. In
consequence, the use of the dbSNP and PubMed links for
OSIRISv1.2 assessment was discarded.
Thus, a de novo corpus was developed for the purpose of
OSIRISv1.2 evaluation. A starting set of 578 abstracts was
obtained using the PubMed [22] search engine and the
following search query:
"Pathological Conditions, Signs and Symptoms" [MeSH]
AND "Polymorphism, Single Nucleotide" [MeSH] AND
"Humans" [MeSH] AND hasabstract [text] AND English
[lang] AND ("2004/01/01" [PDAT] : "2005/01/01"
[PDAT]) AND "Chemicals and Drugs Category" [MeSH]
This set is focused to a field of interest to our group and
limited to years 2004 and 2005. As a first step in the anno-
tation process, the set of abstracts was carefully reviewed
to determine if it contained explicit mentions of sequence
variants in the text that allow their mapping to a dbSNP
identifier: the position of the variation in the sequence,
one or both alleles, and the gene to which the variation is
mapped to. Only 311 abstracts included this information
and were retained in the corpus. Thus, these abstracts con-
tained mentions of variations that could potentially be
normalized to dbSNP identifiers (although not all of
them were disambiguated to a dbSNP identifier, see
below). The next step consisted in the manual annotation
of gene and sequence variant occurrences with their data-
base identifiers. Since the process of manual annotation is
very laborious and time consuming, a subset consisting of
the first 105 abstracts (in terms of date of publication) was
selected to perform the full annotation. The quality of the
annotation was prioritised in front of the size of the cor-
pus. Nevertheless, the size of the corpus (n = 105) is sim-
ilar to other corpora used in other evaluations carried out
in the field [19].
The annotation of the abstracts consisted in manual iden-
tification of mentions of genes and variations and their
disambiguation to database identifiers. The NCBI Gene
database was used in the case of genes and HgenetInfoDB
in the case of variations. The text inspection was per-
formed at the level of title and abstract and the resulting
annotations were recorded in the corpus as an XML file
using the Vex editor [45] in the framework of the Eclipse
platform [46]. The result of the annotation is summarized
as follows: from the set of 105 abstracts, 102 abstractsBMC Bioinformatics 2008, 9:84 http://www.biomedcentral.com/1471-2105/9/84
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contained gene mentions that were disambiguated to a
NCBI Gene identifier. The remaining 3 abstracts con-
tained gene mentions that could not be normalized. Fifty
five abstracts contained mentions of variations normal-
ized to dbSNP entries (109 variations), while 50 abstracts
contained mentions of sequence variants that could not
be mapped to dbSNP identifiers (155 variations). The cor-
pus is available to other researchers upon request.
PubMed search queries
The search queries used to select the set of articles related
to the diseases of interest are detailed below. Results pre-
sented in this article correspond to searches conducted on
MEDLINE database updated to August 2007.
For intracranial aneurysm and subarachnoid haemor-
rhage:
("intracranial aneurysm" [TIAB] NOT MEDLINE [SB]) OR
"intracranial aneurysm" [MeSH Terms] OR cerebral aneu-
rysm [Text Word]
("subarachnoid hemorrhage" [TIAB] NOT MEDLINE
[SB]) OR " subarachnoid hemorrhage" [MeSH Terms] OR
subarachnoid hemorrhage [Text Word]
For breast cancer:
("breast neoplasms" [TIAB] NOT Medline [SB]) OR
"breast neoplasms" [MeSH Terms] OR Breast Cancer [Text
Word]
The search query used for compiling the corpus was:
"Pathological Conditions, Signs and Symptoms" [MeSH]
AND "Polymorphism, Single Nucleotide" [MeSH] AND
"Humans" [MeSH] AND hasabstract [text] AND English
[lang] AND ("2004/01/01" [PDAT] : "2005/01/01"
[PDAT]) AND "Chemicals and Drugs Category" [MeSH]
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